Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
41results about How to "Treat symptoms" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Avenanthramide-containing compositions
Methods and compositions for treating or preventing a skin condition, an inflammation, an irritation or an allergy associated with an ectoparasitic infection or infestation on an animal. The methods involve applying to the skin of the animal a pharmaceutical composition that contains a therapeutically effective amount of one or more than one avenanthramide, an optional ecto and / or endo-parasiticidal agent, and a pharmaceutically acceptable diluent or carrier
Owner:CEAPRO
Combination therapy for depression, prevention of suicide, and various medical and psychiatric conditions
InactiveUS7973043B2Preventing disease progression/modifyingDelaying/preventing relapseBiocideNervous disorderInitial treatmentTherapy resistant
The present invention relates to a new method of treatment for persons meeting diagnoses for major depressive disorder, or other unipolar (non-bipolar, non-psychotic and non-treatment resistant) depression. The method comprises administering a combination of two categories of drugs, antipsychotics or dopamine system stabilizers, in combination with a newer antidepressant such as a selective serotonin reuptake inhibitor, as initial treatment or as soon as possible. The method targets the prevention of suicide, and provides other benefits including preventing disease progression development of tolerance toward the antidepressants. Another aspect of the invention relates to using the method for alleviating cognitive distortion and related functional impairment or health risks, and / or using the method for smoking cessation or nicotine withdrawal.
Owner:MIGALY PETER
Fluid filled implants for treating obstructive sleep apnea
ActiveUS20110100376A1Change flexibilityRigidity be changedRestraining devicesSnoring preventionOropharyngeal airwayPalate muscle
An implant for treating obstructive sleep apnea includes a flexible chamber, a fluid reservoir in fluid communication with the flexible chamber, and a fluid transfer assembly in communication with the fluid reservoir and the flexible chamber for transferring fluid therebetween for selectively modifying the rigidity of the flexible chamber. The flexible chamber is implantable within the soft tissue of an oropharyngeal airway of a patient, such as within the tongue, the soft palate, or the pharyngeal wall. The fluid reservoir and the fluid transfer assembly are implantable within the inframandibular region of the patient. The fluid transfer assembly is selectively engageable by the patient for transferring fluid between the two chambers for modifying the rigidity, flexibility, and / or shape of the flexible chamber with minimal or no change to the volume of the implant.
Owner:ETHICON INC
Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
ActiveUS20210101007A1Symptoms improvedGood curative effectDiagnostic recording/measuringSensorsNervous systemPosterior tibial nerve
In some embodiments, systems and methods can include a wearable device with an electrically conductive skin interface that excites the underlying nerves from a transcutaneous surface stimulator. The device may be sized for a range of user sizes with stimulation electrodes positioned to target the appropriate nerves, such as the saphenous and / or tibial nerves. The stimulation could include burst stimulation, and involve receiving an input relating to autonomic nervous system activity of the patient, and modifying at least one brain or spinal cord autonomic feedback loop relating to bladder function based on the input to balance parasympathetic and sympathetic nervous system activity of the patient.
Owner:CALA HEALTH
Method for relieving motion sickness and related apparatus
InactiveUS20110245902A1Relieve symptomsReduces potential confusionTherapeutic coolingTherapeutic heatingMotion sicknessVestibular system
The invention is directed toward a non-chemical method of relieving motion sickness that first includes the step of refrigerating an enhanced earplug. The enhanced earplug has a first portion having a handle and connector. The second portion having a first end and a corresponding second end where the first end is affixed to the first portion through the connector. This second portion also includes a deformable bladder having a cavity and a quantity of coolant maintained within the deformable bladder. The second step is to insert the enhanced earplug into a user's ear canal through use of the handle. The third step is to cool the vestibular system of the user placing the coolant close to the ear drum. A fourth step includes removing the enhanced earplug. These four steps are repeated as necessary prior to engaging in an event, which could cause motion sickness.
Owner:KATZ JAY W
Targeted lysosomal enzyme compounds
InactiveUS20150037311A1Treat symptomsEfficient transportPolypeptide with localisation/targeting motifNervous disorderLysosomeSulfatase
The present invention is related to a compound that includes a lysosomal enzyme and a targeting moiety, for example, where compound is a fusion protein including iduronate-2-sulfatase and Angiopep-2. In certain embodiments, these compounds, owning to the presence of the targeting moiety can crossing the blood-brain barrier or accumulate in the lysosome more effectively than the enzyme alone. The invention also features methods for treating lysosomal storage disorders (e.g., mucopolysaccharidosis Type II) using such compounds.
Owner:ANGLACHEM INC
Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation
PendingUS20210252278A1Reduce inflammationTreat symptomsDiagnostic signal processingInertial sensorsNervous systemBowels diseases
Systems and methods for treating symptoms of an inflammatory gastrointestinal disease in a patient with transcutaneous stimulation of a peripheral nerve are disclosed. The method can include any number of positioning a first peripheral nerve effector on the patient's skin to stimulate the peripheral nerve of the patient, delivering a first electrical nerve stimulation signal transcutaneously to the peripheral nerve through the first peripheral nerve effector, and modifying at least one brain or spinal cord autonomic feedback loop relating to release of neurotransmitters from the autonomic nervous system that modulate synthesis of inflammatory biomarkers and reduce inflammation relating to the inflammatory gastrointestinal disease.
Owner:CALA HEALTH
Treatment of allergic rhinitis using a combination of mometasone and olopatadine
ActiveUS20150272966A1Better therapeutic valueIncrease valueOrganic active ingredientsBiocideDrugFixed dose
The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a human) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
Owner:GLENMARK SPECIALTY
System and method for spinal cord stimulation to treat motor disorders
ActiveUS8688233B2Inhibit nerve impulsesTreat symptomsSpinal electrodesExternal electrodesNerve fiber bundleMedicine
A method for using spinal cord stimulation to treat symptoms of motor disorders includes implanting a stimulation lead within a ventral portion of the epidural space. The lead is implanted with at least a portion of the electrodes facing the spinal cord. In a method for providing therapy to a patient suffering from a motor disorder, electrical stimulation energy is applied to at least one ventral column nerve fiber through the implanted stimulation lead. A peripheral region of the patient's body exhibits the symptoms of the motor disorder, and the ventral column nerve fiber to which the stimulation is applied innervates that peripheral region.
Owner:BOSTON SCI NEUROMODULATION CORP
Targeted iduronate-2-sulfatase compounds
InactiveUS20140335163A1Treat symptomsEfficient transportPolypeptide with localisation/targeting motifNervous disorderLysosomeIduronate Sulfatase
The present invention is related to a compound that includes a lysosomal enzyme and a targeting moiety, for example, where compound is a fusion protein including iduronate-2-sulfatase and Angiopep-2. In certain embodiments, these compounds, owning to the presence of the targeting moiety can crossing the blood-brain barrier or accumulate in the lysosome more effectively than the enzyme alone. The invention also features methods for treating lysosomal storage disorders (e.g., mucopolysaccharidosis Type II) using such compounds.
Owner:ANGLACHEM INC
Drink container with a breath strip
InactiveUS20110027199A1Bad tasteTreat symptomsCosmetic preparationsContainer decorationsSoluble FilmEngineering
The present invention by provides a system for treating the symptoms of a user having a bad breath or taste after drinking a liquid substance. The invention comprises a drink container initially containing the liquid substance consumed by the user. A breath strip assembly forming a strip pouch is carried by the drink container. A single soluble film breath strip is housed in the strip pouch to be accessed by the user and dissolved in the mouth to remove the users bad breath and taste. In one aspect the breath strip assembly comprises a flexible substrate having front and rear surfaces. The rear surface is attached to the drink container using a pressure sensitive rear adhesive between the rear surface and the drink container. A removable film is partially attached to the front surface of the substrate using a pressure sensitive front adhesive on the substrate in a pattern to provide the strip pouch.
Owner:FRYE DANNY +1
Chinese and western integrated medicine composition treating diaper dermatitis of new born children, and preparation method of Chinese and western integrated medicine composition
InactiveCN105616648ANo stimulationDoes not cause atrophyHydroxy compound active ingredientsOintment deliveryHerbal preparationsVitamin C
The invention belongs to the technical field of Chinese herbal preparation, particularly relates to a Chinese and western integrated medicine composition treating diaper dermatitis of new born children, and further discloses a preparation method of the Chinese and western integrated medicine composition. The Chinese and western integrated medicine composition adopts the treating concept of Chinese and western integration, and adopts lithospermum, cortex phellodendri, radix sophorae flavescentis, borneol, folium artemisiae argyi, fructus cnidii, vitamin C and erythromycin ointment as active pharmaceutical ingredients; the integral effective rate of the Chinese and western integrated medicine composition reaches up to 100 percent in the aspect of treating diaper dermatitis; the Chinese and western integrated medicine composition is not only obvious in treating effect, and free of side effects, but also relatively short in treating circle, thereby being obviously better than conventional treatment in the prior art.
Owner:QILU CHILDRENS HOSPITAL OF SHANDONG UNIV
Electrode system, device and method for the treatment of eye diseases, in particular dry eye
ActiveUS20180339151A1Reduce frequencyOvercome disadvantagesEye treatmentExternal electrodesEyelidPower flow
A method for treating an eye, including the step of applying an electromagnetic wave of distorted sinusoidal current with a resonance frequency and having related harmonics on an eye, an eye orbit, a temple, eyelid areas or a part thereof.
Owner:PERI GMBH +1
Herbaceutical Formulations
InactiveUS20160287656A1Improve athletic performanceIncrease synthesisPharmaceutical delivery mechanismMagnoliophyta medical ingredientsEurycoma longifolia
Described are herbaceutical effervescent formulations comprising extracts of Eurycoma longifolia and uses thereof.
Owner:NATURECEUTICALS
Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
ActiveUS11331480B2Relieve symptomsTreat symptomsDiagnostic recording/measuringSensorsNervous systemPosterior tibial nerve
In some embodiments, systems and methods can include a wearable device with an electrically conductive skin interface that excites the underlying nerves from a transcutaneous surface stimulator. The device may be sized for a range of user sizes with stimulation electrodes positioned to target the appropriate nerves, such as the saphenous and / or tibial nerves. The stimulation could include burst stimulation, and involve receiving an input relating to autonomic nervous system activity of the patient, and modifying at least one brain or spinal cord autonomic feedback loop relating to bladder function based on the input to balance parasympathetic and sympathetic nervous system activity of the patient.
Owner:CALA HEALTH
Fluid filled implants for treating obstructive sleep apnea
ActiveUS9326886B2Change flexibilityRigidity be changedRestraining devicesPerson identificationSoft palateMedicine
An implant for treating obstructive sleep apnea includes a flexible chamber, a fluid reservoir in fluid communication with the flexible chamber, and a fluid transfer assembly in communication with the fluid reservoir and the flexible chamber for transferring fluid therebetween for selectively modifying the rigidity of the flexible chamber. The flexible chamber is implantable within the soft tissue of an oropharyngeal airway of a patient, such as within the tongue, the soft palate, or the pharyngeal wall. The fluid reservoir and the fluid transfer assembly are implantable within the inframandibular region of the patient. The fluid transfer assembly is selectively engageable by the patient for transferring fluid between the two chambers for modifying the rigidity, flexibility, and / or shape of the flexible chamber with minimal or no change to the volume of the implant.
Owner:ETHICON INC
Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR-Inhibitors
InactiveUS20190111042A1Unwanted side-effectDrug tolerancePowder deliveryOrganic active ingredientsAtopic dermatitisPsoriasis universalis
Methods of treating symptoms of skin disorders with CCR3 modulating agents are provided. The methods include administering a therapeutically effective amount of the CCR3 modulating agent to the subject, with a concomitant improvement in pruritis, xerosis, or other skin disorder-affected function. Skin disorders upon which the methods of the invention can improve symptoms and causes of the disorders include eczema, bullous pemphigoid, atopic dermatitis, and psoriasis.
Owner:ALKAHEST INC
SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY
ActiveUS20120022002A1Improve visual performanceImprove visual effectsOrganic active ingredientsSenses disorderDrugDrug delivery
The present invention provides an ocular implant comprising siRNA complexed with a transfection agent selected from the group consisting of cationic lipids and short cell penetration peptides, wherein said complex is associated with a biocompatible polymer. Said biocompatible polymer comprises a polymeric matrix configured to release said complex into the eye of a patient at therapeutic levels for a time sufficient to treat an ocular condition or disease.
Owner:ALLERGAN INC
Compositions and methods for application over skin
PendingUS20210213047A1Many functionsReduce viscosityCosmetic preparationsToilet preparationsWater chlorinationBody movement
Disclosed herein are compositions that can form a covering, layer, film, device, and / or prosthetic skin that can be comfortably worn to provide skin barrier function, skin hydration and therapeutic and aesthetic benefits. The present invention provides novel compositions that have low tackiness and form quickly, resulting in a wearable, comfortable (maintains temperature and humidity), breathable, thin, optically invisible, cosmetically elegant, flexible, stretchable, elastic and body-movement conforming, yet long-lasting covering, layer, film, device, and / or prosthetic skin on the skin or any other body surface. The present invention provides novel compositions that can form a covering, layer, film, device, and / or prosthetic skin that works for extended periods in excess of about 24 hours, while retaining function during and after exercising, showering and swimming (in sea-water, fresh water and chlorinated water), steam room (heat at high humidity), and sauna (heat at low humidity).
Owner:SHISEIDO CO LTD
Apparatus for strengthening facial bones and muscle in cosmetic, stroke, and idiopathic facial paralysis patients and methods of use
ActiveUS10549151B2Improve the immunityHigh densityResilient force resistorsFacial boneResistance training
A facial exercise apparatus for facial muscle and bone resistance training and method of use. The facial exercise apparatus includes one or more flexor arms and a mouthpiece stabilizer, each connected to a flexor head connector. The flexor arm(s) extend upward, downward, left or right from the flexor head connector, have contours to place the patient's lips, and provide a resistance force outward from the flexor head connector. In use, a patient places and bites down upon the mouthpiece stabilizer, places a portion of their lips along a contoured portion of one or more of the flexor arms, and pushes their lips toward the center of the flexor head connector against the resistance of the flexor arm(s). When done at regular intervals and increasing resistances, the apparatus can strengthen a patient's facial muscles and bone and reduce the cosmetic appearance of wrinkles on their face.
Owner:MCGHEE PRENTICE CAPRI
Remedy for corneal ulcer
InactiveUS20060094775A1Suppress a vicious circle of activation of corneal stromal cellInhibition of activationBiocideSenses disorderCorneal ulcerTriptolide
The present invention provides a pharmaceutical agent capable of effectively treating corneal ulcer, more particularly, a therapeutic agent for corneal ulcer, which contains triptolide or a derivative thereof or a pharmaceutically acceptable salt thereof.
Owner:NISHIDA +1
Stable compositions comprising heparinoid, acute-acting anesthetic, and buffer
InactiveCN105263503ATreat symptomsImprove or prevent lower urinary tract diseasesAntibacterial agentsOrganic active ingredientsDiseaseInterstitial cystitis
Owner:URIGEN PHARMA INC
Cannabis Treatment of Insomnia, Pain, and Skin Conditions
PendingUS20220071946A1Treat symptomsExtended durationNervous disorderHydroxy compound active ingredientsDiseaseCannabinoid
A pharmaceutical composition for treating one or more symptoms of insomnia is disclosed herein. The pharmaceutical composition includes an amount of cannabidiol (CBD) and an amount of delta-9-tetrahydrocannabinol (THC), wherein the amount of CBD and the amount of THC are effective in treating insomnia. The pharmaceutical composition may include an amount of a selected herb and an amount of another cannabinoid. A pharmaceutical composition for treating one or more symptoms of chronic and acute pain using an amount of CBD and / or THC is also disclosed herein. The pharmaceutical composition may include an amount of another cannabinoid. A pharmaceutical composition for treating one or more symptoms of skin diseases and conditions using CBD and / or THC is also disclosed herein. The pharmaceutical composition may include an amount of another cannabinoid, an essential oil, a permeation enhancer, and / or an anti-bacterial / anti-viral agent.
Owner:ALTE VERDE LLC
Insulated Above Ground Pool
InactiveUS20120071055A1Less energy consumptionReduce operating costLamination ancillary operationsLayered product treatmentRadio frequency energyPolyester
An above-ground pool which consists of a plurality of layers of which there is an inner woven reinforced vinyl layer, a second, foil-laminated, metalized layer which is entrapped between a third woven reinforced vinyl layer. The three layers are then sealed together to form a watertight structure. The inner and outer layer is designed to be able to withstand forces which a typical container would experience. The core of the material is polyester woven which is then encased in durable vinyl. The layers are all combined together to form a water-tight seal by using radio frequency energy to weld the inner and outer layer together to form a permanent seal while the foil laminated, metalized layer is entrapped between the inner and outer layer.
Owner:GILLEBAARD THEODOR FRANCISCUS
Traditional Chinese medicine recipe for treating acne rosacea
InactiveCN105878303AEffective symptomsEffectively treat symptomsDermatological disorderGnetophyta medical ingredientsCapillary hyperpermeabilityBlood capillary
The invention provides a traditional Chinese medicine recipe for treating acne rosacea. The traditional Chinese medicine recipe can be used for effectively relieving the symptoms of the acne rosacea. Raw herba ephedrae sections, raw herba ephedrae roots and Baijiu are used as raw materials, and the traditional Chinese medicine is taken after being decocted with Baijiu. The traditional Chinese medicine recipe has the advantages that the blood capillary permeability can be improved, so that the effects of clearing away heat, drying dampness, nourishing the blood, promoting blood circulation, dispelling wind and arresting itching are achieved.
Owner:李一漩
Olfactory delivery of therapeutic compounds to the central nervous system
PendingUS20210038671A1Non-toxicCost-effectiveOrganic active ingredientsPowder deliveryNeuro-degenerative diseasePsychiatry
The present invention provides materials and methods for treating symptoms of neurological conditions. More specifically, the subject invention provides compositions and methods of their use for treating one or more symptoms and / or comorbidities of a neurological condition such as an infection, a neurodevelopmental disease, and / or a neurodegenerative disease. In preferred embodiments, the composition is administered to the subject via nasal administration.
Owner:LOCUS SOLUTIONS IPCO LLC
Apparatus for strengthening facial bones and muscle in cosmetic, stroke, and idiopathic facial paralysis patients and methods of use
PendingUS20220233913A1Improve the immunityHigh densityPhysical therapyResilient force resistorsFacial boneEngineering
A facial exercise apparatus for facial muscle and bone resistance training and method of use. The facial exercise apparatus includes one or more flexor arms and a mouthpiece stabilizer, each connected to a flexor head connector. The flexor arm(s) extend upward, downward, left or right from the flexor head connector, have contours to place the patient's lips, and provide a resistance force outward from the flexor head connector. In use, a patient places and bites down upon the mouthpiece stabilizer, places a portion of their lips along a contoured portion of one or more of the flexor arms, and pushes their lips toward the center of the flexor head connector against the resistance of the flexor arm(s). When done at regular intervals and increasing resistances, the apparatus can strengthen a patient's facial muscles and bone and reduce the cosmetic appearance of wrinkles on their face.
Owner:MCGHEE PRENTICE CAPRI
Compositions and methods for application over skin
ActiveUS20210213046A1Many functionsReduce viscosityCosmetic preparationsToilet preparationsWater chlorinationBody movement
Disclosed herein are compositions that can form a covering, layer, film, device, and / or prosthetic skin that can be comfortably worn to provide skin barrier function, skin hydration and therapeutic and aesthetic benefits. The present invention provides novel compositions that have low tackiness and form quickly, resulting in a wearable, comfortable (maintains temperature and humidity), breathable, thin, optically invisible, cosmetically elegant, flexible, stretchable, elastic and body-movement conforming, yet long-lasting covering, layer, film, device, and / or prosthetic skin on the skin or any other body surface. The present invention provides novel compositions that can form a covering, layer, film, device, and / or prosthetic skin that works for extended periods in excess of about 24 hours, while retaining function during and after exercising, showering and swimming (in sea-water, fresh water and chlorinated water), steam room (heat at high humidity), and sauna (heat at low humidity).
Owner:SHISEIDO CO LTD
Treatment of allergic rhinitis using a combination of mometasone and olopatadine
ActiveUS10548907B2Increase valueReduce morbidityOrganic active ingredientsPharmaceutical delivery mechanismMometasonePharmaceutical drug
Owner:GLENMARK SPECIALTY
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com